Richard Lifton is president of The Rockefeller University. A physician-scientist who holds M.D. and Ph.D. degrees from Stanford University, Lifton has pioneered the use of genetics and genomics to understand fundamental mechanisms underlying human diseases, including cardiovascular disease, neoplasia, kidney disease, and osteoporosis. He is especially known for research on hypertension and salt intake, work which has informed public health efforts and therapeutic strategies used worldwide. A graduate of Dartmouth College, he did his medical residency at Brigham and Women’s Hospital, and has been on the faculty of Harvard Medical School and Yale University. Lifton is a 2014 Breakthrough Prize winner and a 2008 recipient of the Wiley Prize for Biomedical Sciences. He has received the highest scientific honors of the American Heart Association, the American and International Societies of Nephrology, the American and International Societies of Hypertension, and the Endocrine Society. He is a member of the National Academy of Sciences and the National Academy of Medicine, and was a Howard Hughes Medical Institute Investigator from 1994 until assuming the Rockefeller presidency in 2016. He was co-chair of the planning committee for President Obama’s Precision Medicine Initiative in 2015.